Singapore’s Experience in Primary PCI in the Last Ten Years

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality.
Advertisements

Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia ( TASTE trial) Ole Fröbert, MD, PhD - on behalf of the TASTE investigators Departement.
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
2 Year Clinical Outcomes from the Pivotal RESOLUTE US Study Laura Mauri MD, MSc on behalf of the RESOLUTE US Investigators Brigham and Women’s Hospital.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Primary PCI Treatment of choice for Acute MI.
Masoudi FA et al J Am Coll Cardiol (Published online 27 November 2008) CVN Weekly Interventional Update December 8, 2008 Jeffrey J. Popma and Christopher.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
What Do We Mean By Quality In PCI Institutional Requirements Dr Bernard Prendergast John Radcliffe Hospital, Oxford.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
ACS and Thrombosis in the Emergency Setting
Ambulance Victoria and MonashHEART Acute Myocardial Infarction (Mon-AMI) 12 lead ECG project. An update On behalf of the MonAMI Team A Hutchison, Y Malaiapan,
Absence of Flow-Limiting Coronary Artery Disease Among Patients Undergoing Emergent Cardiac Catheterization For ST Segment Elevation Myocardial Infarction.
” “The Dissociation Between Door-to- Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes”
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Heart Attack Centres: Every Network Should Have (at least) One Dr Rod Stables The Liverpool Heart and Chest Hospital.
Correlation between post-PTCA resolution of ST segment and mortality in STEMI patients First author: Diana Opincariu Co-authors: Carmen Moldovan Daniel.
Door to Balloon Time: Does it Matter? Tale of Two Studies.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
BACKGROUND: COMPARATIVE ANALYSIS OF MORPHOLOGICAL EKG CHANGES AND DOOR-TO-BALLOON TIME IN STEMI Mercy P. Chandrasekaran, Jeffrey Cook, Raj Marok, Carlos.
IABP用于高危PCI有价值吗? Is IABP Valuable for High-Risk PCI?
Agrément FMC N° Conflits d’intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Association of Guideline-Based Admission Treatments.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Women and Cardiovascular Disease
Prehospital NSTEMI Patient Assessment and Treatment
Associate Professor, Honorary Consultant Cardiologist
A Clinical profile of patients enrolled in the Pakistan ACS registry
a cautionary note from SPRINT
a cautionary note from SPRINT
Seatbelt Compliance in Singapore: How Useful are Trauma Registry Data for Injury Prevention?
STEMI ST ELEVATION MYOCARDIAL INFARCTION
Improving Outcomes in Cardiogenic Shock
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry) Kunal Mahajan*, Negi PC,
Clinical need for determination of vulnerable plaques
Eva Kline-Rogers RN, NP, AACC University of Michigan
The European Society of Cardiology Presented by Dr. Saman Rasoul
Is There a Role for Aspiration in STEMI?
Has acute myocardial infarction mortality hit rock bottom
Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
European Heart Association Journal 2007 April
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
Fewer PCIs After Public Reporting Changes in NY
Figure 1 PCI strategies in patients with STEMI and multivessel disease
3-Year Clinical Outcomes From the RESOLUTE US Study
Primary PCI Monitoring Performance
Primary PCI Monitoring Performance
Orlando, March , American College of Cardiology
The European Society of Cardiology Presented by RJ De Winter
Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From.
Global Registry of Acute Coronary Events: GRACE
What oral antiplatelet therapy would you choose?
Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Maintenance of Long-Term Clinical Benefit with
DEScover: One-Year Clinical Results
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Singapore’s Experience in Primary PCI in the Last Ten Years Dr Heerajnarain Bulluck on behalf of Mark Y. Chan Associate Professor Yong Loo-Lin SoM, NUS Senior Consultant, Department of Cardiology, NUHCS Li-Ling Tan1, Huili Zheng2, Khuan-Yew Chow2, Lau Yee How3, Joshua Loh1, Terrance Chua4, Huay-Cheem Tan1, David Foo5, Hean-Yee Ong6, Khim-Leng Tong7, A. Mark Richards1, Mark Y. Chan1 Cardiac Department, National University Heart Centre, National University Hospital, Singapore1 National Registry of Diseases Office, Health Promotion Board, Singapore2 Singapore Cardiac Databank4 National Heart Centre, Singapore3 Tan Tock Seng Hospital, Singapore4 Khoo Teck Puat Hospital, Singapore5 Changi General Hospital, Singapore6

Authors’ Disclosures No disclosures

Management of ST-elevation Myocardial Infarction (STEMI)1,2 Rapid recognition Early revascularization PCI-capable hospital Primary PCI Non-PCI-capable hospital Thromboylsis  Early transfer for PCI Pharmacoinvasive strategy 1 ACCF/AHA (2013) Guideline for Management of ST-Elevation Myocardial infarction 2 ESC (2012) Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

What happens if you have a STEMI in Singapore? No of STEMI receiving primary PCI No of STEMI receiving thrombolysis Singapore Myocardial Infarct Registry, National Registry of Diseases Office

Map of Singapore 5.61 million people Land area: 278 miles2 13 miles

5 Public Hospitals with 24-hr primary PCI service 13 miles 26 miles

Association between D2B time, S2B time & mortality Guidelines set a target door-to-balloon (D2B) time < 90min1,2 Early studies showed that shorter D2B time reduces mortality 3,4 3 Cannon et al. JAMA. 2000;283:2941-2947 4 Gibson et al. Am Heart J. 2008;156:1035-1044

Association between D2B time, S2B time & mortality Guidelines set a target door-to-balloon (D2B) time < 90min1,2 Early studies showed that shorter D2B time reduces mortality 3,4 But subsequent studies showed conflicting evidence Menees et al. N Engl J Med 2013

Association between D2B time, S2B time & mortality Guidelines set a target door-to-balloon (D2B) time < 90min1,2 Early studies showed that shorter D2B time reduces mortality 3,4 But subsequent studies showed conflicting evidence Nallamothu et al. Lancet 2015 Shorter patient-specific times were consistently associated with lower inhospital mortality at the individual-patient level

Association between D2B time, S2B time & mortality Correlation between symptom-to-balloon (S2B) time & mortality? S2B time = total ischemic time But evidence is inconsistent 3,5,6 3 Cannon et al. JAMA. 2000;283:2941-2947 4 Gibson et al. Am Heart J. 2008;156:1035-1044 5 Brodie et al. J Am Coll Cardiol.1998;32:1312-1319 6 Giuseppe De Luca et al. J Am Coll Cardiol. 2003;42:991-7

Aims Among STEMI patients undergoing primary PCI in Singapore, what is the relationship between D2B time & all-cause inhospital mortality S2B & all-cause inhospital mortality

Methods Observational, retrospective study from 1 Jan 2007 to 31 Dec 2013 Data sources Singapore Myocardial Infarct Registry (SMIR) National registry with data from all unselected patients presenting with AMI to local hospitals Data obtained from MediClaims database Hospital inpatient discharge summary Death Registry Screening of abnormal troponins from hospital laboratories Trained research personnel to review each case Singapore Cardiac Data Bank (SCDB) All patients undergoing PCI in Singapore

Methods Inclusion criteria STEMI patients who underwent primary PCI at public hospitals Singapore citizens or Permanent Residents Exclusion criteria D2B time > 3 hours Patients who have been transferred from another facility Inpatients Patients presented to private hospitals Requirement for consent and ethics approval was waived

Patient demographics Year Total (n=7597) 2007 (n=742) 2008 (n=829) 2009 (n=1120) 2010 (n=1115) 2011 (n=1182) 2012 (n=1252) 2013 (n=1357) P value Mean age (year) 58.2 57.4 57.9 58.0 58.1 58.6 58.8 0.075 Male (%) 86.2 86.4 84.8 85.8 87.3 87.5 85.9 0.610 Ethnicity (%) - Chinese - Malay - Indian Others 62.1 20.1 16.1 1.8 63.6 16.0 17.3 2.3 61.3 21.1 16.4 1.2 61.9 19.6 16.8 1.7 64.0 19.7 14.7 1.6 62.6 19.5 16.6 1.4 61.4 21.3 15.0 2.2 60.4 21.5 16.3 1.9 0.459

Clinical history Year Total (n=7597) 2007 (n=742) 2008 (n=829) 2009 2010 (n=1115) 2011 (n=1182) 2012 (n=1252) 2013 (n=1357) P value Hyperten-sion (%) 51.5 50.5 52.5 49.1 51.0 53.7 0.332 Diabetes (%) 27.0 28.0 28.1 25.9 27.3 27.4 26.7 26.4 0.912 Smoking (%) 63.7 61.4 63.6 64.6 62.8 65.4 0.652 Dyslipide-mia (%) 44.3 41.5 41.6 42.7 46.0 47.1 46.1 0.025

Correlating D2B time, S2B time with inhospital mortality…

Temporal trend: D2B time and mortality Median D2B time (P<0.001) Median D2B time (min) Mortality (%) Inhospital mortality (P=0.593) Year

Temporal trend: S2B time and mortality Median S2B time (P<0.001) Median S2B time (min) Mortality (%) Inhospital mortality (P=0.593) Year

BUT… No change in inhospital mortality despite temporal reduction in D2B & S2B times BUT… What if we analyze the results differently? Patient-level instead of temporal trend Correlation between D2B and mortality

Mortality according to D2B time D2B time (min) No of patients (n) n=136 n=2896 n=2276 n=1139 n=438 n=212

Mortality according to S2B time S2B time (min) No of patients (n) n=29 n=1320 n=1856 n=1265 n=758 n=504 n=1865

At the patient-specific level… D2B time Every 10 min decrease 10.5% reduction in inhospital mortality (95% CI 6.2-16.1%) S2B time Every 60 min decrease 0.6% reduction in inhospital mortality (95% CI 0.0-1.8%)

Conclusion D2B time is more strongly associated with inhospital mortality than S2B time D2B time still remains as an important performance indicator Highly quantifiable Highly objective

Thank you!